Interestingly, we noticed that, although S100A7 is overexpressed in both ER− and ER+ breast cancer patients, there is a significant mutual-exclusivity of S100A7 and ER expression in human breast tumors (Additional file 1: Figures S1–S2). Here, ESR1 is linked to breast cancer.